Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.
by on Tuesday, August 7th, 2012 | No Comments
Condition: Hepatocellular Carcinoma With Portal Vein Thrombosis
Interventions: Procedure: Endoscopic Variceal Ligation; Drug: Carvedilol
Sponsors: Institute of Liver and Biliary Sciences, India; Institute of Liver and Biliary Sciences, India
Not yet recruiting – verified August 2012
Here is the original post: Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.
